Cardinal Health 2015 Annual Report Download - page 26

Download and view the complete annual report

Please find page 26 of the 2015 Cardinal Health annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 91

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91

Selected Financial Data
25 Cardinal Health | Fiscal 2015 Form 10-K
Selected Financial Data
The consolidated financial data below includes all business combinations as of the date of acquisition that occurred during these periods. The
following selected consolidated financial data should be read in conjunction with the consolidated financial statements and related notes and
“Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
(in millions, except per common share amounts) 2015 2014 2013(1) 2012 2011
Earnings Data:
Revenue $ 102,531 $91,084 $ 101,093 $ 107,552 $102,644
Operating Earnings $ 2,161 $ 1,885 $ 996 $1,792 $1,514
Earnings from continuing operations $ 1,212 $ 1,163 $ 335 $1,070 $966
Earnings/(loss) from discontinued operations 33(1)(1)(7)
Net earnings $ 1,215 $ 1,166 $ 334 $1,069 $959
Basic earnings/(loss) per common share:
Continuing operations $3.65 $3.41 $0.98 $3.10 $2.77
Discontinued operations 0.01 0.01 — — (0.02)
Net basic earnings per common share $ 3.66 $3.42 $0.98 $3.10 $2.75
Diluted earnings/(loss) per common share:
Continuing operations $3.61 $3.37 $0.97 $3.06 $2.74
Discontinued operations 0.01 0.01 — — (0.02)
Net diluted earnings per common share $ 3.62 $3.38 $0.97 $3.06 $2.72
Cash dividends declared per common share $1.4145 $1.2500 $1.0900 $0.8825 $0.8000
Balance Sheet Data:
Total assets $30,142 $26,033 $25,819 $24,260 $22,846
Long-term obligations, less current portion 5,211 3,171 3,686 2,418 2,175
Shareholders’ equity 6,256 6,401 5,975 6,244 5,849
(1) During the fourth quarter of fiscal 2013, we recognized a non-cash goodwill impairment charge of $829 million ($799 million, net of tax) related to our Nuclear Pharmacy
Services division.